A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer
Pancreatic cancer has one of the highest mortality rates among cancers, and a combination of nab-paclitaxel with gemcitabine remains the cornerstone of first-line therapy. However, major advances are required to achieve improvements in patient outcomes. For this reason, several research groups have...
Saved in:
Main Author: | Chapa, Christian |
---|---|
Other Authors: | Roacho-Pérez, Jorge Alberto, Stevens, Jazmín Cristina, López juárez, Karina, Lomelí Tiscareño, Kimberly Michelle |
Format: | Artículo |
Language: | en_US |
Published: |
2022
|
Subjects: | |
Online Access: | https://doi.org/10.3390/life12030327 https://www.mdpi.com/2075-1729/12/3/327/htm |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pancreatic Cancer Treatment by Nab-Paclitaxel with Gemcitabine Combination
by: Chapa, Christian
Published: (2022) -
Venom as therapeutic weapon to combat dreadful diseases of 21st century: A systematic review on cancer, TB, and HIV/AIDS
by: Khusro, Ameer
Published: (2018) -
Immunotherapy in Combination with Chemotherapy for Triple-Negative Breast Cancer
Published: (2023) -
Social characteristics of drug offense inmates in the State of Sonora
by: Francisco Manuel Piña Osuna
Published: (2021) -
Thermosensitive hydrogel for in situ-controlled methotrexate delivery
Published: (2021)